Analysts See $0.17 EPS for Supremex Inc. (SXP); 8 Bullish Analysts Covering DBV Technologies S.A. (DBVT)

January 14, 2018 - By Vivian Park

Analysts expect Supremex Inc. (TSE:SXP) to report $0.17 EPS on February, 15.They anticipate $0.01 EPS change or 6.25% from last quarter’s $0.16 EPS. T_SXP’s profit would be $4.83 million giving it 6.88 P/E if the $0.17 EPS is correct. After having $0.11 EPS previously, Supremex Inc.’s analysts see 54.55% EPS growth. It closed at $4.68 lastly. It is up 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 10 analysts covering DBV Technologies (NASDAQ:DBVT), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. DBV Technologies had 20 analyst reports since August 11, 2015 according to SRatingsIntel. The rating was maintained by Citigroup with “Buy” on Monday, October 2. The firm has “Buy” rating by Citigroup given on Wednesday, March 16. Morgan Stanley downgraded DBV Technologies S.A. (NASDAQ:DBVT) rating on Monday, October 23. Morgan Stanley has “Hold” rating and $25.0 target. On Friday, October 23 the stock rating was initiated by Bank of America with “Buy”. The rating was maintained by Morgan Stanley on Friday, October 6 with “Overweight”. As per Thursday, June 1, the company rating was maintained by Jefferies. Barclays Capital initiated the shares of DBVT in report on Thursday, December 3 with “Overweight” rating. The rating was maintained by Leerink Swann with “Buy” on Monday, October 23. Societe Generale downgraded the shares of DBVT in report on Tuesday, October 24 to “Sell” rating. Jefferies maintained it with “Buy” rating and $51.0 target in Thursday, August 31 report. See DBV Technologies S.A. (NASDAQ:DBVT) latest ratings:

17/11/2017 Broker: JMP Securities Rating: Buy New Target: $30.0
31/10/2017 Broker: Societe Generale Rating: Hold Upgrade
24/10/2017 Broker: Societe Generale Rating: Sell Downgrade
23/10/2017 Broker: Morgan Stanley Rating: Hold New Target: $25.0 Downgrade
23/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $58 New Target: $30 Maintain
23/10/2017 Broker: Leerink Swann Rating: Buy New Target: $49.0 Maintain
23/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $50.0 Maintain
06/10/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $70 New Target: $72 Maintain
02/10/2017 Broker: Citigroup Rating: Buy Old Target: $43 New Target: $57 Maintain
31/08/2017 Broker: Jefferies Rating: Buy New Target: $51.0 Maintain

The stock decreased 0.38% or $0.1 during the last trading session, reaching $26.29. About 88,880 shares traded. DBV Technologies S.A. (NASDAQ:DBVT) has risen 16.91% since January 14, 2017 and is uptrending. It has outperformed by 0.21% the S&P500.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. The company has market cap of $1.29 billion. The Company’s lead product candidate is Viaskin Peanut, an immunotherapy product, which is in Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults. It currently has negative earnings. The firm is also developing Viaskin Milk that is in Phase II clinical trial for the treatment of Immunoglobulin E mediated cowÂ’s milk protein allergy and milk-induced eosinophilic esophagitis; Viaskin Egg, a pre-clinical stage product for the treatment of henÂ’s egg allergy; and booster vaccine for Bordatella pertussis.

Supremex Inc. manufactures and sells envelopes, and packaging and specialty products in North America. The company has market cap of $132.94 million. It offers translucent envelopes, custom envelopes, stock envelopes, digital window envelopes, high efficiency envelopes, Extended Envelope, EnviroSafe, and self-seal envelopes. It has a 9.05 P/E ratio. The firm also provides packaging products, such as Conformer corrugate mailers, auto boxes, tear resistant PaperTyger mailers, board mailers, Conformer presentation folders, Conformer heavy duty mailers, Conformer paperboard mailers, poly mailers, and Enviro-logiX bubble mailers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Vivian Park







Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: